Last Updated: June 17, 2026

FENTANYL-62 Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Fentanyl-62, and when can generic versions of Fentanyl-62 launch?

Fentanyl-62 is a drug marketed by Difgen Pharms, Mylan Technologies, Specgx Llc, and Zydus Pharms. and is included in four NDAs.

The generic ingredient in FENTANYL-62 is fentanyl. There are thirty-one drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the fentanyl profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for FENTANYL-62?
What are the global sales for FENTANYL-62?
What is Average Wholesale Price for FENTANYL-62?

Summary for FENTANYL-62

US Patents:	0
Applicants:	4
NDAs:	4

US Patents and Regulatory Information for FENTANYL-62

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Difgen Pharms	FENTANYL-62	fentanyl	FILM, EXTENDED RELEASE;TRANSDERMAL	077449-007	Dec 6, 2017	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Zydus Pharms	FENTANYL-62	fentanyl	FILM, EXTENDED RELEASE;TRANSDERMAL	209655-005	Jan 24, 2023		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Mylan Technologies	FENTANYL-62	fentanyl	FILM, EXTENDED RELEASE;TRANSDERMAL	076258-007	Dec 29, 2014	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Specgx Llc	FENTANYL-62	fentanyl	FILM, EXTENDED RELEASE;TRANSDERMAL	077154-007	Jan 14, 2020	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.